Cargando…

Metformin Alleviates Hepatic Steatosis and Insulin Resistance in a Mouse Model of High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Promoting Transcription Factor EB-Dependent Autophagy

Nonalcoholic fatty liver disease (NAFLD) results from an abnormal accumulation of lipids within hepatocytes, and is commonly associated with obesity, insulin resistance, and hyperlipidemia. Metformin is commonly used to treat type 2 diabetes mellitus and, in recent years, it was found to play a pote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dan, Ma, Yicheng, Liu, Jianjun, Deng, Yi, Zhou, Bo, Wen, Yu, Li, Mingke, Wen, Daiyan, Ying, Yunyan, Luo, Sufeng, Shi, Chunjing, Pu, Guangyu, Miao, Yinglei, Zou, Chenggang, Chen, Yuanli, Ma, Lanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346235/ https://www.ncbi.nlm.nih.gov/pubmed/34366846 http://dx.doi.org/10.3389/fphar.2021.689111

Ejemplares similares

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Autophagy induced by H. pylori VacA regulated the survival mechanism of the SGC7901 human gastric cancer cell line
por: Luo, Juan, et al.
Publicado: (2021)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease
por: Zhang, Dan, et al.
Publicado: (2022)

Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
por: Pinyopornpanish, Kanokwan, et al.
Publicado: (2021)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
por: Ulasoglu, Celal, et al.
Publicado: (2021)

Gut microbiome determines therapeutic effects of OCA on NAFLD by modulating bile acid metabolism
por: Liu, Jianjun, et al.
Publicado: (2023)

Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis
por: Wang, Xingchun, et al.
Publicado: (2022)

Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)
por: Wu, Jiayu, et al.
Publicado: (2018)

Correction: Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis
por: Wang, Xingchun, et al.
Publicado: (2022)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis
por: Clarke, John D., et al.
Publicado: (2015)

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling
por: Ma, Ning, et al.
Publicado: (2021)

Targeting Epigenetic Mechanisms to Alleviate Alcoholic Steatosis
por: Mandrekar, Pranoti
Publicado: (2020)

Effects of obesity and 10 weeks metformin treatment on liver steatosis
por: Hakkak, Reza, et al.
Publicado: (2021)

Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed?
por: Baardman, R., et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Herbicide Widespread: The Effects of Pethoxamid on Nonalcoholic Fatty Liver Steatosis In Vitro
por: Pirozzi, Anna Virginia Adriana, et al.
Publicado: (2020)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Metformin in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Kazemi, Rozana, et al.
Publicado: (2012)

Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice
por: Li, Long, et al.
Publicado: (2021)

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway
por: Zhu, Wenqiang, et al.
Publicado: (2022)

Trapping of normal EB1 ligands in aggresomes formed by an EB1 deletion mutant
por: Riess, Nick P, et al.
Publicado: (2005)

EB1 and EB3 regulate microtubule minus end organization and Golgi morphology
por: Yang, Chao, et al.
Publicado: (2017)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
por: Choi, Naeun, et al.
Publicado: (2019)

Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis
por: Jiang, Wenjiao, et al.
Publicado: (2020)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Recent studies with EB virus.
por: Epstein, M. A.
Publicado: (1975)

Has the Polyploid Wave Ebbed?
por: Levin, Donald A.
Publicado: (2020)

Diagnostic performance of magnetic resonance technology in detecting steatosis or fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis
por: Wang, Xiao-min, et al.
Publicado: (2018)

Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats
por: Cheng, Bin, et al.
Publicado: (2021)

Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein
por: LIU, FANG, et al.
Publicado: (2014)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
por: Shao, Congxiang, et al.
Publicado: (2022)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g2glguvmgvr7agtclhjoef3aph